In a first study, the anti-tumor necrosis factor-α (TNF-α) antibody infliximab, which blocks the interaction of TNF-α with cell-surface receptors, showed a highly significant effect on symptoms of depression in psoriasis patients [ 38 ].
← all excerpts
Immunological Approaches in the Diagnosis and Treatment of Psychiatric Disorders: A Historical Overview.
1
—
—